CYTK vs HAL · rev $18.5M vs P/E 9.3, $19.05B cap
Cytokinetics Inc (CYTK) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported CYTK revenue for 2024-12-31 was $18.5M. Net income was -$589.5M. Revenue was up 145.3% from 2023-12-31 to 2024-12-31. CYTK currently screens at market cap $4.05B.
HAL does not have a complete income-statement cache yet.
CYTK currently screens at market cap $4.05B. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the CYTK and HAL stock pages for the full models.
Not investment advice.